On air · 1 of 3 networks
Delve Health
- delvehealth.com
- Healthcare & Life Sciences
- US
- 33 employees
Delve Health’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 54. Watch Delve Health with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksNov 2026 | Checked | Next step |
|---|---|---|---|---|---|
| None recorded | 0 | Checked 30 Oct 2026 | See all 54 ads → | ||
| Meta | None recorded | 0 | No active ads recorded on the Meta Ad Library | Checked 19 Oct 2026 | Collect them with the API → |
| Running | 9 | Ads on the Google Ads Transparency Center | Checked 27 Oct 2026 | Collect them with the API → |
Delve Health has no live LinkedIn ads. Its Facebook page had no active ads on 19 Oct 2026, and we recorded 9 Google ads on 27 Oct 2026.
Latest ads
- LINKEDIN · IMAGESince 26 Mar 2026
Long-term post-market evidence rarely fails suddenly. It degrades quietly through missed follow-up, wearable discontinuity, and fragmented recovery workflows. Most sponsors invest in endpoint design. Few operate execution continuity. Delve Health supports sustained follow-up discipline across PMCF, post-approval, and real-world programs.
- LINKEDIN · IMAGESince 25 Mar 2026
Digital endpoints are often deployed across multiple vendors. eCOA, wearables, analytics, and patient engagement operate in parallel — not as one execution system. Without continuity ownership, long-duration studies carry hidden evidence risk. Delve provides a unified execution layer across post-market and real-world programs.
- LINKEDIN · IMAGESince 25 Mar 2026
Regulators do not only assess endpoints. They assess whether longitudinal evidence remains interpretable and defensible. Sustained follow-up quality determines post-approval evidence credibility. Delve supports execution continuity across PMCF, registries, and real-world follow-up models.
- LINKEDIN · IMAGESince 29 Sept 2025
Learn how digital measures in clinical trials, such as gait tracking and real-time health data, are redefining drug development. Delve Health shows how digital tools speed up trials, reduce costs, and improve patient outcomes.
- LINKEDIN · IMAGESince 29 Sept 2025
Discover how Delve Health’s ePRO/eCOA solutions — combined with wearables and concierge support — make clinical trials more patient-centric, improving engagement, retention, and outcomes.
- LINKEDIN · IMAGESince 29 Sept 2025
Clinical trials don’t fail because we lack technology. They fail because patients drop out, sites get overwhelmed, and protocol leaks that change faster than systems can keep up. Most eCOA vendors digitized the diary. Our team has been working hard to re-imagine the experience. ✨ Flat-fee licensing that ends the back-and-forth. ✨ Translations validated with real patients and caregivers. ✨ Concierge teams in 102+ languages, not just a helpdesk script. ✨ 32 AI agents already live, nudging patients before they disengage. ✨ Protocol amendments in days — not weeks. ✨ Zero data loss. Ever. Ahead of DPharm in Philadelphia, we’re sharing our new whitepaper: Beyond Digital Diaries: Why Delve Health’s eCOA Isn’t Just Another Vendor Solution. 📥 https://lnkd.in/g4eqrEDz And if you’re at DPharm — stop by Booth #310 to see how we’re making eCOA work in the real world. #DPharm #ClinicalTrials #eCOA #DecentralizedTrials #PatientEngagement #DigitalHealth #PharmaInnovation #DPharm2025
6 of 54 adsSign up to see every Delve Health ad, filter by format and date, and get alerts on new ones.
See all 54 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.